NCT00036335View on ClinicalTrials.gov

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

January 31, 2003

Conditions

DepressionPain

Interventions

DRUG

Duloxetine Hydrochloride

Trial Locations (25)

Unknown

Peoria

Burbank

Fresno

St. Petersburg

West Palm Beach

Atlanta

Oakbrook Terrace

Springfield

Glen Burnie

Farmington Hills

Nashua

Clementon

Moorestown

Albany

Olean

Cincinnati

Toledo

Philadelphia

Austin

Lake Jackson

San Antonio

Woodstock

Richmond

Seattle

Brown Deer

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00036335 - Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain | Biotech Hunter | Biotech Hunter